(Q44545203)

4 December 2017

The impact of therapeutic doses of paracetamol on serum total antioxidant capacity (English)

1 reference

4 December 2017

1 reference

Nuttall SL

1

1 reference

4 December 2017

Khan JN

2

1 reference

4 December 2017

Thorpe GH

3

1 reference

4 December 2017

Langford N

4

1 reference

4 December 2017

Kendall MJ

5

1 reference

4 December 2017

language of work or name

1 reference

1 August 2003

1 reference

Journal of Clinical Pharmacy and Therapeutics

4 December 2017

1 reference

4 December 2017

28

1 reference

4 December 2017

4

1 reference

4 December 2017

289-294

1 reference

Frequent paracetamol use and asthma in adults

4 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Paracetamol sales and atopic disease in children and adults: an ecological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Paracetamol use in pregnancy and wheezing in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Does paracetamol cause asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

The Treatment of Acetaminophen Poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Oxidative stress in allergic respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Oxidative stress and lung inflammation in airways disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Effect of fasting on hyperoxic lung injury in mice. The role of glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Glutathione and its role in cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Altered lung antioxidant status in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Total antioxidant capacity by enhanced chemiluminescence: contribution of urate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2003.00493.X

10.1046/J.1365-2710.2003.00493.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference